#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16162	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2361	836.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1594	1594	C	1001	C	1001	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16162	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2361	836.6	0	HET	.	.	.	C260T	.	260	260	C	670	670	C	975	C,T	776,199	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26408	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4112	801.2	0	.	n	.	0	T695C	SNP	695	695	T	1290	1290	C	1055	C,G,T	1050,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26408	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4112	801.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1932	1932	A	1079	A,G	1078,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26408	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4112	801.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2566	2566	C	877	C,T	876,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26408	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4112	801.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3192	3192	T	866	T,G,C	861,4,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26408	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4112	801.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2640	2640	A	802	A,G	801,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2372	folP	852	852	100.0	folP.l6.c17.ctg.1	1952	151.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1248	1250	AGC	225;230;228	A;G,A;C	225;229,1;228	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5410	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3742	179.8	1	SNP	p	S91F	0	.	.	271	273	TCC	781	783	TCC	198;197;198	T,G;C;C,A	197,1;197;197,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5410	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3742	179.8	1	SNP	p	D95G	0	.	.	283	285	GAC	793	795	GAC	206;205;205	G;A,G;C	206;204,1;205	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5410	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3742	179.8	1	SNP	p	D95N	0	.	.	283	285	GAC	793	795	GAC	206;205;205	G;A,G;C	206;204,1;205	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2110	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1816	144.8	1	SNP	p	G45D	1	.	.	133	135	GAC	728	730	GAC	247;248;247	G;A,C;C	247;247,1;247	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1260	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1361	114.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5316	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3420	194.0	1	SNP	p	D86N	0	.	.	256	258	GAC	803	805	GAC	243;243;243	G;A,T;C,T,A	243;242,1;241,1,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5316	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3420	194.0	1	SNP	p	S87I	0	.	.	259	261	AGT	806	808	AGT	242;238;236	A,C;G;T,G	240,2;238;235,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5316	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3420	194.0	1	SNP	p	S87R	0	.	.	259	261	AGT	806	808	AGT	242;238;236	A,C;G;T,G	240,2;238;235,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5316	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3420	194.0	1	SNP	p	S87W	0	.	.	259	261	AGT	806	808	AGT	242;238;236	A,C;G;T,G	240,2;238;235,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5316	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3420	194.0	1	SNP	p	S88P	0	.	.	262	264	TCC	809	811	TCC	235;239;242	T;C;C	235;239;242	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4568	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3106	183.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1770	1772	GGC	263;264;261	G;G,T;C	263;263,1;261	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1459	1461	GCA	274;275;273	G;C,A;A	274;274,1;273	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1462	1464	ATC	273;269;269	A;T;C	273;269;269	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1474	1476	GTG	262;260;259	G;T;G,T	261;260;258,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1474	1476	GTG	262;260;259	G;T;G,T	261;260;258,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1978	1980	ACC	241;241;242	A;C,T;C	241;240,1;242	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2032	2034	GCG	234;233;232	G;C;G,T	234;233;231,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2032	2034	GCG	234;233;232	G;C;G,T	234;233;231,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2155	2157	GGC	238;236;238	G;G,T;C	238;234,2;238	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2164	2166	GGC	242;243;243	G,A;G,T;C,G	240,2;242,1;242,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4286	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2857	186.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2182	2184	CCG	254;254;252	C,G;C,T;G,A	252,2;253,1;251,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5940	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3579	207.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2726	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2321	146.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	841	841	C	214	C,T	213,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	639	641	GAA	255;257;258	G;A;A	255;257;258	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	T87A	NONSYN	259	261	ACT	786	788	GCT	234;230;230	G;C;T,C	234;230;229,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	792	794	AGC	215;214;213	A,G;G;C	214,1;214;213	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	884	885	CG	206;207	C;G	206;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	887	889	CAG	203;202;204	C;A;G	203;202;204	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	891	893	AAA	209;214;209	A,C;A;A	207,2;214;209	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	954	956	GAA	220;224;224	G;A;A,G	220;224;223,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	978	980	GCA	248;252;253	G;C,T;A	248;251,1;253	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1161	1163	GAT	230;229;228	G;A;T	230;229;228	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1164	1166	GGT	227;222;222	G;G;T	227;222;222	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1179	1181	ATG	209;210;211	A;T;G	209;210;211	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1293	1295	GCA	202;204;203	G;C,G;A	202;203,1;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1296	1298	ACG	202;202;203	A;C,A;G	202;201,1;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1299	1301	GGG	201;203;204	G;G;G,T	201;203;203,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1302	1304	GTT	204;207;204	G;T,A;T	204;206,1;204	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1362	1364	GTA	219;220;218	G;T;A	219;220;218	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1401	1403	ACT	225;228;227	A;C;T	225;228;227	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1407	1409	GAT	231;234;234	G;A;T	231;234;234	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1419	1421	CAC	242;245;247	C;A;C	242;245;247	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	1	SNP	p	G120K	1	.	.	358	360	AAG	884	886	CGG	206;207;203	C;G;G	206;207;203	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	1	SNP	p	A121D	1	.	.	361	363	GAC	887	890	CGC	203;204;205	C;G;C	203;204;205	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2768	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1716	196.0	1	SNP	p	D121N	0	.	.	361	363	GAC	887	890	CGC	203;204;205	C;G;C	203;204;205	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9974	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5321	233.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2242	2244	AAT	258;259;258	A;A;T,G	258;259;257,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1508	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1412	133.1	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	271;270;269	A;T;G,A	271;270;268,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
